|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-10.97/1.50
|
企业价值
722.66M
|
资产负债 |
每股账面净值
12.67
|
现金流量 |
现金流量率
--
|
损益表 |
收益
1.02B
|
每股收益
20.49
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/19 07:19 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products. |